Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Jean Carlos Lipreri da Silva, Hugo Passos Vicari & João Agostinho Machado-Neto. (2023) Perspectives for Targeting Ezrin in Cancer Development and Progression. Future Pharmacology 3:1, pages 61-79.
Crossref
Crossref
Jean Carlos Lipreri da Silva, Maria Fernanda Lopes Carvalho, Livia Bassani Lins de Miranda, Bruna Oliveira de Almeida, Keli Lima & João Agostinho Machado-Neto. (2022) NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs 40:4, pages 728-737.
Crossref
Crossref
Yanan Song, Xiaokun Ma, Miao Zhang, Menghan Wang, Guoyu Wang, Ying Ye & Wei Xia. (2020) Ezrin Mediates Invasion and Metastasis in Tumorigenesis: A Review. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Vesselin R. Penchev, Yu-Tai Chang, Asma Begum, Theodore Ewachiw, Christian Gocke, Joey Li, Ross H. McMillan, Qiuju Wang, Robert Anders, Luigi Marchionni, Anirban Maitra, Aykut Uren, Zeshaan Rasheed & William Matsui. (2019) Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Research 17:4, pages 929-936.
Crossref
Crossref
M. Bartova, J. Hlavaty, Y. Tan, C. Singer, K. Pohlodek, J. Luha & I. Walter. (2017) Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. Clinical & Experimental Metastasis 34:5, pages 333-344.
Crossref
Crossref
Yong Chen, Hong-Li Chuan, Sheng-Yuan Yu, Chu-Zhong Li, Zhe-Bao Wu, Gui-Lin Li & Ya-Zhuo Zhang. (2017) A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas. World Neurosurgery 100, pages 514-521.
Crossref
Crossref
Lei-Miao Yin, Ting-Ting Duan, Luis Ulloa & Yong-Qing Yang. 2018. Reviews of Physiology, Biochemistry and Pharmacology Vol. 174. Reviews of Physiology, Biochemistry and Pharmacology Vol. 174
1
23
.
Teresita N. J. Flores-Téllez, Tania V. Lopez, Verónica Rocío Vásquez Garzón & Saúl Villa-Treviño. (2015) Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma. PLOS ONE 10:7, pages e0131605.
Crossref
Crossref
Shigeki Suzuki, Genichiro Ishii, Rie Matsuwaki, Shinya Neri, Hiroko Hashimoto, Chisako Yamauchi, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Mitsutomo Kohno, Kanji Nagai & Atsushi Ochiai. (2014) Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment. Journal of Cancer Research and Clinical Oncology 141:3, pages 475-484.
Crossref
Crossref
Junjie Piao, Shusen Liu, Yunjie Xu, Changan Wang, Zhenhua Lin, Yunzhi Qin & Shuangping Liu. (2015) Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Experimental and Molecular Pathology 98:1, pages 1-6.
Crossref
Crossref
Hye Kyoung Shin, Byung Jun Ryu, Sik-Won Choi, Seong Hwan Kim & Kyunglim Lee. (2015) Inactivation of Src-to-Ezrin Pathway: A Possible Mechanism in the Ouabain-Mediated Inhibition of A549 Cell Migration. BioMed Research International 2015, pages 1-10.
Crossref
Crossref
Tiefeng Jin, Jingchun Jin, Xiangyu Li, Songnan Zhang, Yun Ho Choi, Yingshi Piao, Xionghu Shen & Zhenhua Lin. (2014) Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer. BMC Cancer 14:1.
Crossref
Crossref
L Brown, A Waseem, I N Cruz, J Szary, E Gunic, T Mannan, M Unadkat, M Yang, F Valderrama, E A O′Toole & H Wan. (2013) Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation. Oncogene 33:18, pages 2363-2374.
Crossref
Crossref
Jiahua Zhou, Yongjiang Feng, Ketao Tao, Zhanhai Su, Xiaojin Yu, Jie Zheng, Lihua Zhang & Detong Yang. (2014) The expression and phosphorylation of ezrin and merlin in human pancreatic cancer. International Journal of Oncology.
Crossref
Crossref
Sang Hyub Lee, Haeryoung Kim, Jin-Hyeok Hwang, Eun Shin, Hye Seung Lee, Dae Wook Hwang, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han & Byung Hyo Cha. (2014) CD24 and S100A4 Expression in Resectable Pancreatic Cancers With Earlier Disease Recurrence and Poor Survival. Pancreas 43:3, pages 380-388.
Crossref
Crossref
Jienan Kong, Yan Li, Shuangping Liu, Haidan Jin, Yongjun Shang, Chengshi Quan, Yulin Li & Zhenhua Lin. (2013) High expression of ezrin predicts poor prognosis in uterine cervical cancer. BMC Cancer 13:1.
Crossref
Crossref
K. Alexa Orr Gandy, Mohamad Adada, Daniel Canals, Brittany Carroll, Patrick Roddy, Yusuf A. Hannun & Lina M. Obeid. (2013) Epidermal growth factor‐induced cellular invasion requires sphingosine‐1‐phosphate/sphingosine‐1‐phosphate 2 receptor‐mediated ezrin activation. The FASEB Journal 27:8, pages 3155-3166.
Crossref
Crossref
Yasunori Oda, Shinichi Aishima, Katsuya Morimatsu, Akifumi Hayashi, Koji Shindo, Minoru Fujino, Yusuke Mizuuchi, Masami Hattori, Masao Tanaka & Yoshinao Oda. (2013) Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas. Human Pathology 44:8, pages 1487-1498.
Crossref
Crossref
K Boman, A H Larsson, U Segersten, E Kuteeva, H Johannesson, B Nodin, J Eberhard, M Uhlén, P-U Malmström & K Jirström. (2013) Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer. British Journal of Cancer 108:11, pages 2321-2328.
Crossref
Crossref
Shinichi Aishima. (2012) Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein‑Barr virus infection. Molecular and Clinical Oncology.
Crossref
Crossref
Fredrik Jörgren, Mef Nilbert, Eva Rambech, Pär-Ola Bendahl & Gudrun Lindmark. (2012) Ezrin expression in rectal cancer predicts time to development of local recurrence. International Journal of Colorectal Disease 27:7, pages 893-899.
Crossref
Crossref
Xiao-Qin Zhang, Guo-Ping Chen, Tao Wu, Jian-Ping Yan & Jian-Ying Zhou. (2012) Expression and Clinical Significance of Ezrin in Non–Small-Cell Lung Cancer. Clinical Lung Cancer 13:3, pages 196-204.
Crossref
Crossref
Angela Y. Wehr, Wei-Ting Hwang, Ian A. Blair & Kenneth H. Yu. (2012) Relative Quantification of Serum Proteins from Pancreatic Ductal Adenocarcinoma Patients by Stable Isotope Dilution Liquid Chromatography–Mass Spectrometry. Journal of Proteome Research 11:3, pages 1749-1758.
Crossref
Crossref
Shuhui Zheng, Jinghe Huang, Kewen Zhou, Chengxi Zhang, Qiuling Xiang, Zhi Tan, Tinghuai Wang & Xiaodong Fu. (2011) 17β-Estradiol Enhances Breast Cancer Cell Motility and Invasion via Extra-Nuclear Activation of Actin-Binding Protein Ezrin. PLoS ONE 6:7, pages e22439.
Crossref
Crossref
Yunxiao Meng, Zhaohui Lu, Shuangni Yu, Qiang Zhang, Yihui Ma & Jie Chen. (2010) Ezrin promotes invasion and metastasis of pancreatic cancer cells. Journal of Translational Medicine 8:1.
Crossref
Crossref